Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT07390331

A Patient Activation Approach to Implementing Depression Treatment in Cardiac Patients

Led by Columbia University · Updated on 2026-03-06

200

Participants Needed

1

Research Sites

152 weeks

Total Duration

On this page

Sponsors

C

Columbia University

Lead Sponsor

N

National Institute on Aging (NIA)

Collaborating Sponsor

AI-Summary

What this Trial Is About

This study, which is being conducted as part of a Quality Improvement (QI) Initiative at Columbia University Irving Medical Center, will test whether delivering the iHeart DepCare tool increases real world reach and adoption of depression treatment among CHD patients. As part of the QI Initiative, Clinic Navigators will administer and record (in EPIC) depression screening in advance of primary care and cardiology appointments. Eligible patients with elevated depressive symptoms will be randomized to receive usual care vs. the iHeart DepCare tool in conjunction with brief motivational, technical and navigation support per patient preference. Aim 1: To test the effect of iHeart DepCare on depression treatment optimization (primary outcome) among coronary heart disease patients with elevated depressive symptoms. Aim 2: To explore the effect of iHeart DepCare on implementation outcomes, including provider referrals, among coronary heart disease patients with elevated depressive symptoms.

CONDITIONS

Official Title

A Patient Activation Approach to Implementing Depression Treatment in Cardiac Patients

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Over 18 years of age
  • PHQ9 or PHQ8 score 8 or higher
  • History of coronary heart disease confirmed by specific medical codes
  • Appointment with a primary care provider or cardiologist in an integrated care setting at NYP/Columbia
  • Has an active primary care provider at NYP/Columbia recorded in the electronic health record
Not Eligible

You will not qualify if you...

  • Not English or Spanish speaking
  • History of severe mental illness including bipolar disorder, schizophrenia, chronic or recurrent depression, or history of suicide attempts or self-inflicted injuries
  • Dementia
  • Had an integrated mental health visit in the last 3 months as shown in medical records
  • Enrolled in the post-implementation period of IRB# AAAR9175

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Columbia University Irving Medical Center

New York, New York, United States, 10032

Actively Recruiting

Loading map...

Research Team

N

Nathalie Moise, MD, MS, FAHA

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

HEALTH_SERVICES_RESEARCH

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here